Transfusion Medicine And Hemotherapy
- 期刊全称:Transfusion Medicine And Hemotherapy
- 简称:TRANSFUS MED HEMOTH
- ISSN:1660-3796
- ESSN:1660-3796
- 研究方向:医学 - 免疫学
投稿咨询
免费咨询
2023最新分区
Transfusion Medicine And Hemotherapy英文简介
This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of homeostasis, immuno-hematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.
Transfusion Medicine And Hemotherapy中文简介
《Transfusion Medicine And Hemotherapy》是一本由KARGER出版商出版的专业医学期刊,该刊创刊于2003年,刊期Bimonthly,该刊已被国际权威数据库SCIE、SCI收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 3区,小类学科:血液学 3区;免疫学 3区;在JCR(Journal Citation Reports)分区等级为Q2。该刊发文范围涵盖血液学等领域,旨在及时、准确、全面地报道国内外血液学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为4.04,平均审稿速度较慢,6-12周。
中科院分区最新升级版(当前数据版本:2021年12月最新升级版)
大类学科 |
分区 |
小类学科 |
分区 |
Top期刊 |
综述期刊 |
医学 |
3区 |
HEMATOLOGY
血液学
IMMUNOLOGY
免疫学
|
3区
3区
|
否 |
否 |
JCR分区(当前数据版本:2021-2022年最新版)
JCR分区等级 |
JCR所属学科 |
分区 |
影响因子 |
Q2 |
HEMATOLOGY |
Q2 |
4.04 |
IMMUNOLOGY |
Q3 |
期刊指数
影响因子 |
h-index |
Gold OA文章占比 |
研究类文章占比 |
OA开放访问 |
平均审稿速度 |
4.04 |
33 |
33.11% |
78.43% |
未开放 |
较慢,6-12周 |
IF值(影响因子)趋势图